Review




Structured Review

Castle Biosciences 31 gene expression profile
31 Gene Expression Profile, supplied by Castle Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+profiling/31+expression+gene+profile/pm42279412-3-7-12
Average 86 stars, based on 1 article reviews
31 gene expression profile - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

Gene Expression:

Article Title: Malignant Transformation of Ocular Melanocytoma to Uveal Melanoma: A Clinicopathologic Review of Three Novel Unsuspected Cases of a Likely Under-Recognized Phenomenon, With Review of the Literature and Molecular Genetic Data.
Article Snippet: • PURPOSE: To describe three cases of, and review the current knowledge regarding, malignant transformation of ocular melanocytoma (OM) to uveal melanoma (UM).. • DESIGN: Retrospective clinicopathological case series and review of the literature.. • METHODS: Clinical records and histopathology from three patients diagnosed with UM arising from a previously unsuspected OM were critically reviewed at a single academic institution.

Article Title: Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions
Article Snippet: .. The risk of metastatic development for patients with UM can also be predicted using the Gene Expression Profiling (GEP; Castle Biosciences, Phoenix, AZ, USA) of the primary tumour, a commercially available test based on a 15-gene array conducted on a microfluidics quantitative polymerase chain reaction (PCR) platform, which allows accurate UM testing even from small needle biopsy samples [ , ]. ..

Article Title: Precision medicine and Treat-to-Target approach in atopic dermatitis: enhancing personalized care and outcomes
Article Snippet: .. On the other hand, Castle Biosciences uses non-invasive skin scrapings and gene expression profiling to distinguish between psoriasis, AD, and other conditions like mycosis fungoides. ..

Article Title: Displacement of submacular hemorrhage with intravitreal tissue plasminogen activator following 27 gauge transvitreal fine needle aspiration biopsy for choroidal melanoma
Article Snippet: .. Gene expression profiling from choroidal biopsy revealed Class 1A, PRAME positive (Castle Biosciences, Phoenix, AZ), and the choroidal lesion was monitored every four months following treatment. ..

Article Title: Commercial Diagnostics and Emerging Precision Medicine Technologies in Psoriasis and Atopic Dermatitis
Article Snippet: In this review, we discuss the commercially available Mindera Health “Mind.PxTM” patch test to guide psoriasis biologic selection. .. We also explore ongoing clinical studies by Castle Biosciences examining gene expression profiling for the diagnosis of psoriasis/AD, and for the prediction of treatment outcomes in psoriasis and AD. .. Mindera Health is a company focusing on precision medicine.

Article Title: Precision medicine and Treat-to-Target approach in atopic dermatitis: enhancing personalized care and outcomes.
Article Snippet: Two companies, Mindera Health and Casle Biosciences, are pioneering non-invasive technologies to m g u c ddress these challenges.33 Mindera Health developed the ind.PxTM dermal patch, which uses microneedles to col- ect RNA from skin samples. .. Machine learning and genetic iomarkers predict patient responses to specific psoriais biologics, reducing trial-and-error treatments.34 Clinical tudies (e.g., STAMP-2, MATCH) demonstrated its economic nd clinical benefits, showing high predictive accuracy n severe psoriasis cases, and reducing biological therapy osts.33 On the other hand, Castle Biosciences uses nonnvasive skin scrapings and gene expression profiling to istinguish between psoriasis, AD, and other conditions like 33 ycosis fungoides. .. Preliminary studies identified distinct enetic markers linked to treatment responses in patients sing drugs like dupilumab and risankizumab.35 Ongoing linical trials aim to validate these findings and optimize Anais Brasileiros de Dermatologia 2025;100():501135 Table 3 Investigational approaches for precision medicine in atopic dermatitis.

Article Title: Adjuvant Therapy of Melanoma
Article Snippet: .. ANDTrametinib 2 mg once daily vs. placebos for 12 months November 2012 July 2015 Crizotinib ( {"type":"clinical-trial","attrs":{"text":"NCT02223819","term_id":"NCT02223819"}} NCT02223819 ) 30 Open label phase II study in high-risk uveal melanoma as determined by gene expression profiling (Castle Biosciences, class II) RFS OS, disease specific survival, toxicity Crizotinib 250 mg B.I.D. per 4 week cycle for 12 cycles August 2014 August 2016 Dabrafenib and Trametinib (COMBI-NEO, {"type":"clinical-trial","attrs":{"text":"NCT02231775","term_id":"NCT02231775"}} NCT02231775 ) 84 Randomized open-label phase II study of neoadjuvant and adjuvant Dabrafenib /Trametinib and surgery compared to surgery alone in clinical stage IIIB-C or oligometastatic stage IV melanoma 1 year RFS N/A Dabrafenib 150 mg B.I.D. and Trametinib 2 mg daily for 8 weeks prior to surgery; then surgery; then Dabrafenib/Trametinib in patients with stable/responding disease for an additional 44 weeks October 2014 October 2017 Open in a separate window Key: NS not significant; S significant; HR hazard ratio; DFS disease free survival; RFS relapse free survival; OS overall survival; irAE immune-related adverse events Ongoing adjuvant studies in high-risk resected melanoma Recent work suggests that BRAF-mutated melanomas have greater tumor immunogenicity but paradoxically decreased antitumor immunity suggesting that combinations of targeted and immunomodulatory therapies may have additive, or synergistic, benefits. ..

Article Title: Comparative Analysis of Staging and Metastatic Risk Stratification Systems for Cutaneous Squamous Cell Carcinoma.
Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article.

Real-time Polymerase Chain Reaction:

Article Title: Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions
Article Snippet: .. The risk of metastatic development for patients with UM can also be predicted using the Gene Expression Profiling (GEP; Castle Biosciences, Phoenix, AZ, USA) of the primary tumour, a commercially available test based on a 15-gene array conducted on a microfluidics quantitative polymerase chain reaction (PCR) platform, which allows accurate UM testing even from small needle biopsy samples [ , ]. ..

Polymerase Chain Reaction:

Article Title: Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions
Article Snippet: .. The risk of metastatic development for patients with UM can also be predicted using the Gene Expression Profiling (GEP; Castle Biosciences, Phoenix, AZ, USA) of the primary tumour, a commercially available test based on a 15-gene array conducted on a microfluidics quantitative polymerase chain reaction (PCR) platform, which allows accurate UM testing even from small needle biopsy samples [ , ]. ..

Biomarker Discovery:

Article Title: Commercial Diagnostics and Emerging Precision Medicine Technologies in Psoriasis and Atopic Dermatitis
Article Snippet: In this review, we discuss the commercially available Mindera Health “Mind.PxTM” patch test to guide psoriasis biologic selection. .. We also explore ongoing clinical studies by Castle Biosciences examining gene expression profiling for the diagnosis of psoriasis/AD, and for the prediction of treatment outcomes in psoriasis and AD. .. Mindera Health is a company focusing on precision medicine.

Adjuvant:

Article Title: Adjuvant Therapy of Melanoma
Article Snippet: .. ANDTrametinib 2 mg once daily vs. placebos for 12 months November 2012 July 2015 Crizotinib ( {"type":"clinical-trial","attrs":{"text":"NCT02223819","term_id":"NCT02223819"}} NCT02223819 ) 30 Open label phase II study in high-risk uveal melanoma as determined by gene expression profiling (Castle Biosciences, class II) RFS OS, disease specific survival, toxicity Crizotinib 250 mg B.I.D. per 4 week cycle for 12 cycles August 2014 August 2016 Dabrafenib and Trametinib (COMBI-NEO, {"type":"clinical-trial","attrs":{"text":"NCT02231775","term_id":"NCT02231775"}} NCT02231775 ) 84 Randomized open-label phase II study of neoadjuvant and adjuvant Dabrafenib /Trametinib and surgery compared to surgery alone in clinical stage IIIB-C or oligometastatic stage IV melanoma 1 year RFS N/A Dabrafenib 150 mg B.I.D. and Trametinib 2 mg daily for 8 weeks prior to surgery; then surgery; then Dabrafenib/Trametinib in patients with stable/responding disease for an additional 44 weeks October 2014 October 2017 Open in a separate window Key: NS not significant; S significant; HR hazard ratio; DFS disease free survival; RFS relapse free survival; OS overall survival; irAE immune-related adverse events Ongoing adjuvant studies in high-risk resected melanoma Recent work suggests that BRAF-mutated melanomas have greater tumor immunogenicity but paradoxically decreased antitumor immunity suggesting that combinations of targeted and immunomodulatory therapies may have additive, or synergistic, benefits. ..

Immunopeptidomics:

Article Title: Adjuvant Therapy of Melanoma
Article Snippet: .. ANDTrametinib 2 mg once daily vs. placebos for 12 months November 2012 July 2015 Crizotinib ( {"type":"clinical-trial","attrs":{"text":"NCT02223819","term_id":"NCT02223819"}} NCT02223819 ) 30 Open label phase II study in high-risk uveal melanoma as determined by gene expression profiling (Castle Biosciences, class II) RFS OS, disease specific survival, toxicity Crizotinib 250 mg B.I.D. per 4 week cycle for 12 cycles August 2014 August 2016 Dabrafenib and Trametinib (COMBI-NEO, {"type":"clinical-trial","attrs":{"text":"NCT02231775","term_id":"NCT02231775"}} NCT02231775 ) 84 Randomized open-label phase II study of neoadjuvant and adjuvant Dabrafenib /Trametinib and surgery compared to surgery alone in clinical stage IIIB-C or oligometastatic stage IV melanoma 1 year RFS N/A Dabrafenib 150 mg B.I.D. and Trametinib 2 mg daily for 8 weeks prior to surgery; then surgery; then Dabrafenib/Trametinib in patients with stable/responding disease for an additional 44 weeks October 2014 October 2017 Open in a separate window Key: NS not significant; S significant; HR hazard ratio; DFS disease free survival; RFS relapse free survival; OS overall survival; irAE immune-related adverse events Ongoing adjuvant studies in high-risk resected melanoma Recent work suggests that BRAF-mutated melanomas have greater tumor immunogenicity but paradoxically decreased antitumor immunity suggesting that combinations of targeted and immunomodulatory therapies may have additive, or synergistic, benefits. ..



Similar Products

86
10X Genomics spatial gene expression profiling xenium in situ technology
Spatial Gene Expression Profiling Xenium In Situ Technology, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+profiling/pm42288489-252-0-9
Average 86 stars, based on 1 article reviews
spatial gene expression profiling xenium in situ technology - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Castle Biosciences 31 gene expression profile
31 Gene Expression Profile, supplied by Castle Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+profiling/31+expression+gene+profile/pm42279412-3-7-12
Average 86 stars, based on 1 article reviews
31 gene expression profile - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Heumann Pharma gene expression profiles
Gene Expression Profiles, supplied by Heumann Pharma, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+profiling/expression+gene+profiles/pm42270780-275-22-33
Average 86 stars, based on 1 article reviews
gene expression profiles - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Caliper Life Sciences algorithms gepia gene expression profiling interactive analysis
Algorithms Gepia Gene Expression Profiling Interactive Analysis, supplied by Caliper Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+profiling/algorithms+analysis+expression+gene+gepia+interactive+profiling/pm42242229-657-61-96
Average 86 stars, based on 1 article reviews
algorithms gepia gene expression profiling interactive analysis - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
10X Genomics chromium fixed rna profiling flex gene expression assay
Chromium Fixed Rna Profiling Flex Gene Expression Assay, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+profiling/rna/bio_rxiv__64898__2026__05__04__722452-254-26-34
Average 86 stars, based on 1 article reviews
chromium fixed rna profiling flex gene expression assay - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Biotechnology Information gene expression profiles
Gene Expression Profiles, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+profiling/expression+gene+omnibus+%E2%80%A2/us12595518-37-11-24
Average 86 stars, based on 1 article reviews
gene expression profiles - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Castle Biosciences decisiondx um gene expression profile test
Decisiondx Um Gene Expression Profile Test, supplied by Castle Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+profiling/31+expression+gene+profile/pm42267753-86-170-175
Average 86 stars, based on 1 article reviews
decisiondx um gene expression profile test - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Biotechnology Information gene expression profile dataset gse208411
Gene Expression Profile Dataset Gse208411, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+profiling/expression+gene+omnibus+%E2%80%A2/pm41775051-82-3-19
Average 86 stars, based on 1 article reviews
gene expression profile dataset gse208411 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Glaxo Smith gene expression profiling
Gene Expression Profiling, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+profiling/expression+gene+profiling/bio_rxiv__64898__2026__03__06__710054-241-0-6
Average 86 stars, based on 1 article reviews
gene expression profiling - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Omics Data Automation gene expression tpm profiles
Gene Expression Tpm Profiles, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+profiling/data+expression+gene/pm41508432-371-11-1
Average 86 stars, based on 1 article reviews
gene expression tpm profiles - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results